To further explore the potential of caveolin-3+ EV as a biomarker for the severity of myocardial infarction, the correlation of EV with CK-MBmax, an established marker related to infarct size and outcome after myocardial infarction (32), was determined (Table 4). Here, CAV3 is linked to myocardial infarction.